Showing results (811-820 of 1,072) with videos related to
Sort By:
Pageof 108
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation]Jin-Song Jia, Dong-Ping Liu, Xiao-Jun Huang, et al.Leukemia & Lymphoma|April 5, 2013
Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndromeYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.Bone Marrow Transplantation|April 13, 2026
Chronic graft-versus-host disease after haploidentical transplantation in aplastic anemia: clinical characteristics, risk factors, and survival outcomesMing-Hao Lin, Sheng-Nan Gao, Xiao-Jun Huang, et al.Zhonghua Nei Ke Za Zhi|February 12, 2008
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]Yu Wang, Kai-yan Liu, Lan-ping Xu, et al.Clinical Transplantation|March 27, 2015
Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adultsYao Chen, Yu Wang, Lan-Ping Xu, et al.Journal of Hematology & Oncology|March 7, 2019
Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplantChen-Hua Yan, Yu Wang, Jing-Zhi Wang, et al.Cancer|March 17, 2017
Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trialYing-Jun Chang, Yu Wang, Xiao-Dong Mo, et al.Leukemia Research|April 23, 2013
NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypesYan-Rong Liu, Hong-Hu Zhu, Guo-Rui Ruan, et al.British Journal of Haematology|August 18, 2021
PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort studyFei-Fei Tang, Sheng-Ye Lu, Xiao-Su Zhao, et al.Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Abnormal expression of programmed cell death 5 gene in multiple myeloma patients]Li Bao, Guo-Rui Ruan, Xi-Jing Lu, et al.Pageof 108